Jean‐Paul Guastalla

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

Medicine, Oncology, Pharmacology +13

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

Isabelle Ray‐Coquard, Claire Cropet, M. van Glabbeke et al. · Cancer Research · 2009 · 797 citations · Full text

Medicine, Oncology, Chemotherapy +13

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen et al. · Annals of Oncology · 2005 · 466 citations

Medicine, Gynecology, Oncology +17

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

Isabelle Treilleux, Jean‐Yves Blay, Nathalie Bendriss‐Vermare et al. · Clinical Cancer Research · 2004 · 444 citations · Full text

Life Sciences, Immunology, Oncology +17

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations

Medicine, Oncology, Pharmacology +17